ãã°ã€ã³ã§çµç¹ã»å¥çŽäŸ¡æ Œãã芧ãã ããã
ãµã€ãºãéžæããŠãã ãã
衚瀺ã倿Žãã
ãã®ååã«ã€ããŠ
å®éšåŒïŒãã«è¡šèšæ³ïŒ:
C17H11ClF3N3
CASçªå·:
ååé:
349.74
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.51
PubChem Substance ID:
Assay:
≥99% (HPLC)
Form:
solid
Storage condition:
OK to freeze, protect from light
ãã¯ãã«ã«ãµãŒãã¹
ãå°ãã®ããšãããã°ãçµéšè±å¯ãªãã¯ãã«ã«ãµãŒãã¹ããŒã ãã客æ§ããµããŒãããŸãã
ãæäŒãããŸãQuality Segment
assay
≥99% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
DMSO: 50 mg/mL
shipped in
ambient
storage temp.
2-8°C
SMILES string
C1=CC(=CC(=C1)Cl)C2=NC(=NC=C2)NC3=CC=C(C=C3)C(F)(F)F
InChI key
XTKUZTBZRIJTFR-UHFFFAOYSA-N
General description
A cell-permeable pyrimidinylphenylamine compound that directly and reversibly targets aryl hydrocarbon receptor (AhR) with high-affinity, and induces AhR signaling. Reported to act as an immunomodulator with anti-inflammatory properties. Potently suppresses IgE secretion in B-cells with an IC50 of ~2 nM, and inhibits dendritic cells-mediated T-cell proliferation and cytokine production. Further, decreases lung eosinophilia in B-cell-deficient mice, and allergic inflammation. Downregulates PU.1 transcription factor, and impairs human monocytes and Langerhans dendritic cells differentiation.
Packaging
Packaged under inert gas
Other Notes
Platzer, B., et al. 2009. J. Immunol.183, 66.
Hauben, E., et al. 2008. Blood118, 1214.
Lawrence, B.P., et al. 2008. Blood112, 1158.
Ettmayer, P., et al. 2006. Am. J. Respir. Crit. Care Med.173, 599.
Hauben, E., et al. 2008. Blood118, 1214.
Lawrence, B.P., et al. 2008. Blood112, 1158.
Ettmayer, P., et al. 2006. Am. J. Respir. Crit. Care Med.173, 599.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
ä¿ç®¡åé¡
11 - Combustible Solids
WGK
WGK 2
åŒç«ç¹ (F)
Not applicable
åŒç«ç¹ïŒÂ°CïŒ
Not applicable
ææ°ããŒãžã§ã³ã®ãããããéžæããŠãã ããïŒ
以åãã®è£œåãè³Œå ¥ããã ããããšãããå Žå
ææžã©ã€ãã©ãªã§ãæè¿è³Œå ¥ãã補åã®ææžãæ€çŽ¢ã§ããŸãã